TIL logo

TILInstil Bio Inc

$7.92
$0.01
(0.13%)
Today
Closed $7.92
$0.00
(0.00%)
After Hours
Updated: 04:10 PM EDT
Reported EarningsMay 15
Mkt Cap$53.78M
Vol12,411.00
40

Bearish Sentiment

How do you feel about TIL?

News
all
press releases
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Instil Bio, Inc. - TIL
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Instil Bio, Inc. - TIL INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Instil Bio...
PR Newswire
News Placeholder
More News
News Placeholder
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Instil Bio, Inc. - TIL
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Instil Bio, Inc. - TIL INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Instil Bio...
PR Newswire
News Placeholder
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Instil Bio, Inc. - TIL
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Instil Bio, Inc. - TIL INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Instil Bio...
PR Newswire
News Placeholder
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Instil Bio, Inc. - TIL
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Instil Bio, Inc. - TIL INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Instil Bio...
PR Newswire
News Placeholder
Instil Bio Pulls Plug On Lead Drug Development
Instil Bio stock falls after the company ends development of its lead cancer drug and exits a licensing deal, raising new questions about its pipeline and next steps.read more...
Benzinga
News Placeholder
Instil Bio, Inc. (TIL) Is Up 4.07% in One Week: What You Should Know
Zacks
News Placeholder
Wall Street Analysts Think Instil Bio (TIL) Could Surge 246.68%: Read This Before Placing a Bet
Zacks
News Placeholder
Are You Looking for a Top Momentum Pick? Why Instil Bio, Inc. (TIL) is a Great Choice
Zacks
News Placeholder
Summit Therapeutics Stock Nosedives on Mixed NSCLC Study Results
Zacks
News Placeholder
Instil Bio (TIL) Upgraded to Buy: What Does It Mean for the Stock?
Zacks
<
1
2
...
>

Advertisement|Remove ads.